Skopos Labs, Inc. Novo Nordisk A S Transaction History
Skopos Labs, Inc.
- $330 Million
- Q4 2024
A detailed history of Skopos Labs, Inc. transactions in Novo Nordisk A S stock. As of the latest transaction made, Skopos Labs, Inc. holds 2,931 shares of NVO stock, worth $230,640. This represents 0.08% of its overall portfolio holdings.
Number of Shares
2,931
Previous 169
1634.32%
Holding current value
$230,640
Previous $20,000
1160.0%
% of portfolio
0.08%
Previous 0.01%
Shares
2 transactions
Others Institutions Holding NVO
# of Institutions
1,928Shares Held
318MCall Options Held
5.49MPut Options Held
7.78M-
Jennison Associates LLC20.2MShares$1.59 Billion1.5% of portfolio
-
Morgan Stanley New York, NY14.4MShares$1.13 Billion0.13% of portfolio
-
Bank Of America Corp Charlotte, NC14.3MShares$1.13 Billion0.14% of portfolio
-
Ken Fisher Fisher Asset Management, LLC | Camas, Wa13.3MShares$1.05 Billion0.65% of portfolio
-
Fayez Sarofim & CO Houston, TX12.2MShares$961 Million3.76% of portfolio
About NOVO NORDISK A S
- Ticker NVO
- Exchange OTC
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 2,257,289,984
- Market Cap $178B
- Description
- Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Biopharm. The Diabetes and Obesity care segment provides products in the areas of insulins, GLP-1 and related delivery systems, oral antidiabeti...